Nanotechnology’s applications in drug formulation and delivery are well-established, but what about in consumer products? That’s where the industry is headed, and that’s why it’ll eventually eclipse biotech in size and profitability, according to Liquidia Technologies CEO Neal Fowler. Speaking at last week’s Nanotech Commercialization Conference in North Carolina, Fowler said his company’s proprietary nanoparticle manufacturing tech has applications far beyond medicine. The company has a partnership with Procter & Gamble ($PG), aiming to branch out into consumer products. Fowler said a huge market is waiting for nanotech companies; it’s just a matter of harnessing the field’s potential into practical uses.
Apr 21, 2012 Comments Off